PLEASANTON, CA--(Marketwired - Sep 11, 2014) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the location and agenda for its 2014 investor and analyst day. The event will be held on September 18th, 2014 from 10:00 a.m. ET to 12:00 p.m. ET at the Park Hyatt New York in New York City.
The event will highlight the Company's long-term growth and profitability profile, additional marketing and expansion plans, R&D pipeline and will include an interactive physician panel to discuss the CoolSculpting® technology and the market for non-invasive body contouring.
Please RSVP by emailing RSVP@zeltiq.com by September 16, 2014.
Event: ZELTIQ Investor Day
Date: September 18, 2014
Time: 10:00 a.m. ET to 12:00 p.m. ET
Location: Park Hyatt New York - ONYX Room (153 W 57th Street)
The agenda will include:
- Executive Management Presentations on Corporate Strategy and Expansion Plans, Long-term Growth and Profitability Profile, Product Pipeline and Market Dynamics
- Q&A with Executive Management
- Interactive Physician Panel with Audience Q&A
ZELTIQ is honored to welcome the following physicians as participants for the event:
- Grant Stevens, M.D., F.A.C.S. -- Marina Plastic Surgery, Los Angeles, CA
- Elizabeth Tanzi, M.D., F.A.A.D. -- Washington Institute of Dermatologic Laser Surgery, Washington, D.C.
- David P. Rapaport, M.D., F.A.C.S. -- Manhattan Plastic Surgeon and founder of CoolSpa, New York, NY
An audio webcast with live slide presentations will be available by visiting the investor relations section of ZELTIQ's website at www.coolsculpting.com. A replay of the presentation will be available for 90 days.
About ZELTIQ®
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.
